Signal Genetics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Signal Genetics Inc
CIK #0001590750
EDGAR Form CIK 2011 - 2026
10-K [0001590750]
10-Q [0001590750]
3 [0001590750]
4 [0001590750]
5 [0001590750]
8-K [0001590750]
D [0001590750]
SC 13D [0001590750]
SC 13G [0001590750]
Form 13D/13G Filer Form 13D/13G Subject Filed
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2026-06-26]
Bellevue Group AG Viridian Therapeutics Inc de [2026-05-15]
Deep Track Capital LP Viridian Therapeutics Inc de [2026-05-08]
Kynam Capital Management LP Viridian Therapeutics Inc de [2025-05-15]
Commodore Capital LP Viridian Therapeutics Inc de [2025-04-11]
Perceptive Advisors LLC Viridian Therapeutics Inc de [2024-01-29]
State Street Corp Viridian Therapeutics Inc de [2024-01-24]
FMR LLC Viridian Therapeutics Inc de [2024-01-10]
Venrock Opportunities Fund LP Viridian Therapeutics Inc de [2023-12-08]
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2023-05-11]
View All
Form 3/4/5 Subject 2011 - 2026
Miragen Therapeutics Inc
Cain Christopher W
Morris Arlene
Gheuens Sarah
Kiselak Tomas
Ajer Jeffrey Robert
Moses Jennifer K
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund II LP
Fairmount Funds Management LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 5,169
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 6,267 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 9,409
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 9,409 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 3,138 $29.32 92,006
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 1,724 $29.32 50,548
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 7,627 $29.32 223,624
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 18,357
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 18,357 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 6,267
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 5,169 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 2,091 $29.32 61,308
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 176,550 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 119,300 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 23,850 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 102,850 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 20,550 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 35,300 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 111,900 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 559,600 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com